Your Location:Home > Products > Pharmaceutical intermediates >683-10-3

Product Details
InChI:InChI=1/C19H39NO2/c1-7-8-9-10-11-12-13-14-15-16-19(2,3)17(18(21)22)20(4,5)6/h17H,7-16H2,1-6H3
The phase diagram of the system n-dodecy...
An efficient method for the synthesis of...
Disclosed are a variety of amphoteric co...
The present invention discloses a lauryl...
The utility model provides a gel emulsif...
The invention relates to a production de...
Dodecyl-dimethyl-[(4-nitro-phenylcarbamoyl)-methyl]-ammonium; bromide
carboxymethyl-dodecyl-dimethyl-ammonium betaine
4-nitro-aniline
| Conditions | Yield |
|---|---|
|
With
water;
palmitate ion;
at 30 ℃;
Rate constant;
other catalysts;
|
Dodecyl-dimethyl-{[methyl-(4-nitro-phenyl)-carbamoyl]-methyl}-ammonium; bromide
carboxymethyl-dodecyl-dimethyl-ammonium betaine
N-methyl(p-nitroaniline)
| Conditions | Yield |
|---|---|
|
With
water;
palmitate ion;
at 30 ℃;
Rate constant;
other catalysts;
|
N,N-dimethylaminododecane
sodium monochloroacetic acid
chloroacetic acid ethyl ester
methyl N-dodecyl-N,N-dimethylglycinate chloride
N-dodecylbetainium chloride
CAS:10605-21-7
CAS:910463-68-2
CAS:90038-01-0
CAS:51-05-8